Tasadenoturev

DB17178InvestigationalGene Therapies

Tasadenoturev: Overview.

Mechanism: Pharmacologically active on Integrin beta-3, Integrin alpha-V, and Histone acetyltransferase p300
Curator reviewed
Also known as: Ad5-DNX-2401 · adenovirus delta 24-RGD, an oncolytic adenovirus genetically modified for treatment of glioma · Delta-24-RGD · Delta-24-RGD-4C · Delta24-RGD
Code names: DNX-2401

Resolves to

Compound

Targets

What you can answer from here — as of October 05, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tasadenoturev, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.